Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Asset Writedowns and Impairment (2021 - 2025)

Health Catalyst (HCAT) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $6.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $6.9 million, compared with a TTM value of $6.9 million through Sep 2025, up 91.67%, and an annual FY2024 reading of $2.2 million, down 46.09% over the prior year.
  • Asset Writedowns and Impairment was $6.9 million for Q3 2025 at Health Catalyst, up from $2.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $6.9 million in Q3 2025 and bottomed at $98000.0 in Q4 2022.
  • Average Asset Writedowns and Impairment over 5 years is $2.8 million, with a median of $2.0 million recorded in 2023.
  • The sharpest move saw Asset Writedowns and Impairment skyrocketed 173.61% in 2022, then skyrocketed 1328.57% in 2023.
  • Year by year, Asset Writedowns and Impairment stood at $1.8 million in 2021, then crashed by 94.56% to $98000.0 in 2022, then surged by 1328.57% to $1.4 million in 2023, then soared by 57.14% to $2.2 million in 2024, then surged by 213.64% to $6.9 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for HCAT at $6.9 million in Q3 2025, $2.2 million in Q1 2024, and $1.4 million in Q4 2023.